• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺动脉高压的诊断时间与诊断负担:对美国全国医疗保健数据的回顾性分析。

Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data.

作者信息

Didden Eva-Maria, Lee Eileen, Wyckmans Julie, Quinn Deborah, Perchenet Loïc

机构信息

Actelion Pharmaceuticals Ltd Allschwil Switzerland.

Janssen Research & Development Spring House Pennsylvania USA.

出版信息

Pulm Circ. 2023 Jan 1;13(1):e12188. doi: 10.1002/pul2.12188. eCollection 2023 Jan.

DOI:10.1002/pul2.12188
PMID:36694845
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9843478/
Abstract

The main aim of this analysis was to investigate time from symptom onset (chronic unexplained dyspnoea [CUD]) to diagnosis of Group 1 pulmonary hypertension (PH)-pulmonary arterial hypertension (PAH)-and to characterize healthcare resource utilization leading up to diagnosis using a nationwide US claims and an electronic health record (EHR) database from Optum. Eligible patients were ≥18 years old at first CUD diagnosis (index event) and had a PAH diagnosis on or after index date. Based on administrative codes, PAH was defined as right heart catheterization (RHC), ≥ 2 PAH diagnoses (1 within a year of RHC), and ≥1 post-RHC prescription for PAH treatment. All values are median (1st quartile-3rd quartile) unless otherwise stated. Of 854,722 patients with CUD in the claims database, 582 (0.1%) had PAH. Time from CUD to PAH diagnosis was 2.26 (0.73-4.22) years. PAH patients experienced 3 (2-4) transthoracic echocardiograms (TTEs), 6 (3-12) specialist visits, and 2 (1-4) hospitalizations during the diagnostic interval. Almost one-third of patients (29%) waited 10 months or more to have a TTE. Findings from the EHR database were broadly similar. Resource utilization during the diagnostic interval was also analyzed in an overall PH cohort: findings were generally similar to the PAH cohort (2 [1-3] TTEs, 4 [2-9] specialist visits and 2 [1-4] hospitalizations). These data indicate a delay in the diagnostic pathway for PAH, and illustrate the burden associated with PAH diagnosis.

摘要

本分析的主要目的是调查从症状发作(慢性不明原因呼吸困难[CUD])到1组肺动脉高压(PH)-肺动脉高压(PAH)诊断的时间,并利用美国全国性索赔数据和来自Optum的电子健康记录(EHR)数据库,对诊断前的医疗资源利用情况进行描述。符合条件的患者在首次CUD诊断(索引事件)时年龄≥18岁,且在索引日期或之后被诊断为PAH。根据管理代码,PAH被定义为右心导管检查(RHC)、≥2次PAH诊断(RHC后1年内1次)以及≥1次RHC后PAH治疗处方。除非另有说明,所有值均为中位数(第1四分位数-第3四分位数)。在索赔数据库中的854,722例CUD患者中,582例(0.1%)患有PAH。从CUD到PAH诊断的时间为2.26(0.73-4.22)年。PAH患者在诊断期间接受了3(2-4)次经胸超声心动图(TTE)检查、6(3-12)次专科就诊以及2(1-4)次住院治疗。几乎三分之一的患者(29%)等待10个月或更长时间才进行TTE检查。EHR数据库的结果大致相似。还对整个PH队列的诊断期间的资源利用情况进行了分析:结果与PAH队列总体相似(2[1-3]次TTE检查、4[2-9]次专科就诊和2[1-4]次住院治疗)。这些数据表明PAH诊断途径存在延迟,并说明了与PAH诊断相关的负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c8/9843478/b5017c99d06d/PUL2-13-e12188-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c8/9843478/111d5de57196/PUL2-13-e12188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c8/9843478/cf5f501e5dfb/PUL2-13-e12188-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c8/9843478/b5017c99d06d/PUL2-13-e12188-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c8/9843478/111d5de57196/PUL2-13-e12188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c8/9843478/cf5f501e5dfb/PUL2-13-e12188-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f9c8/9843478/b5017c99d06d/PUL2-13-e12188-g003.jpg

相似文献

1
Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data.肺动脉高压的诊断时间与诊断负担:对美国全国医疗保健数据的回顾性分析。
Pulm Circ. 2023 Jan 1;13(1):e12188. doi: 10.1002/pul2.12188. eCollection 2023 Jan.
2
Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured population.美国私人保险人群中肺动脉高压患者的额外费用。
Appl Health Econ Health Policy. 2011 Sep 1;9(5):293-303. doi: 10.2165/11592430-000000000-00000.
3
Clinical evaluation of code-based algorithms to identify patients with pulmonary arterial hypertension in healthcare databases.基于编码算法在医疗数据库中识别肺动脉高压患者的临床评估。
Pulm Circ. 2024 Feb 8;14(1):e12333. doi: 10.1002/pul2.12333. eCollection 2024 Jan.
4
Validation of claims-based algorithms for pulmonary arterial hypertension.基于索赔数据的肺动脉高压算法的验证
Pulm Circ. 2018 Apr-Jun;8(2):2045894018759246. doi: 10.1177/2045894018759246.
5
Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data.美国慢性阻塞性肺疾病相关肺动脉高压患者的药物使用情况:一项行政数据的回顾性研究。
BMC Pulm Med. 2022 Oct 18;22(1):383. doi: 10.1186/s12890-022-02167-9.
6
Characterizing pulmonary hypertension-related hospitalization costs among Medicare Advantage or commercially insured patients with pulmonary arterial hypertension: a retrospective database study.对医疗保险优势计划参保者或商业保险覆盖的肺动脉高压患者的肺动脉高压相关住院费用进行特征分析:一项回顾性数据库研究。
Am J Manag Care. 2015 Jan;21(3 Suppl):s47-58.
7
A claims-based, machine-learning algorithm to identify patients with pulmonary arterial hypertension.一种基于索赔数据的机器学习算法,用于识别肺动脉高压患者。
Pulm Circ. 2023 Jun 6;13(2):e12237. doi: 10.1002/pul2.12237. eCollection 2023 Apr.
8
Comparative evaluation of costs and healthcare resource utilization of oral selexipag versus inhaled treprostinil or oral treprostinil in patients with pulmonary arterial hypertension.比较口服塞来昔帕与吸入性曲前列尼尔或口服曲前列尼尔治疗肺动脉高压患者的成本和医疗资源利用。
J Med Econ. 2023 Jan-Dec;26(1):644-655. doi: 10.1080/13696998.2023.2204769.
9
Healthcare burden of pulmonary hypertension owing to lung disease and/or hypoxia.肺部疾病和/或缺氧所致肺动脉高压的医疗负担。
BMC Pulm Med. 2017 Apr 11;17(1):58. doi: 10.1186/s12890-017-0399-1.
10
Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.美国肺动脉高压和慢性血栓栓塞性肺动脉高压的患病率。
Curr Med Res Opin. 2011 Sep;27(9):1763-8. doi: 10.1185/03007995.2011.604310. Epub 2011 Jul 27.

引用本文的文献

1
Gaps in access to pulmonary hypertension care and opportunities for improvement: a multi-site qualitative study.肺动脉高压护理的可及性差距与改善机会:一项多中心定性研究
BMC Pulm Med. 2025 Jul 28;25(1):355. doi: 10.1186/s12890-025-03817-4.
2
Treatment of pulmonary hypertension after seven world symposia.七次世界研讨会后肺动脉高压的治疗
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251342898. doi: 10.1177/17534666251342898. Epub 2025 May 23.
3
Artificial intelligence-based echocardiography assessment to detect pulmonary hypertension.

本文引用的文献

1
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
2
Automated interpretation of systolic and diastolic function on the echocardiogram: a multicohort study.超声心动图中收缩和舒张功能的自动解读:一项多队列研究。
Lancet Digit Health. 2022 Jan;4(1):e46-e54. doi: 10.1016/S2589-7500(21)00235-1. Epub 2021 Dec 1.
3
Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study.
基于人工智能的超声心动图评估以检测肺动脉高压。
ERJ Open Res. 2025 May 12;11(3). doi: 10.1183/23120541.00592-2024. eCollection 2025 May.
4
Development and validation of multimodal deep learning algorithms for detecting pulmonary hypertension.用于检测肺动脉高压的多模态深度学习算法的开发与验证
NPJ Digit Med. 2025 Apr 10;8(1):198. doi: 10.1038/s41746-025-01593-3.
5
Pulmonary veno-occlusive disease: a clinical review.肺静脉闭塞性疾病:临床综述
Breathe (Sheff). 2025 Mar 18;21(1):240098. doi: 10.1183/20734735.0098-2024. eCollection 2025 Jan.
6
Factors Associated with Referral to Expert Providers among Patients with Pulmonary Hypertension.肺动脉高压患者转诊至专家医疗机构的相关因素。
Ann Am Thorac Soc. 2025 Jun;22(6):838-845. doi: 10.1513/AnnalsATS.202408-901OC.
7
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
8
The Diagnostic Accuracy of an Electrocardiogram in Pulmonary Hypertension and the Role of "R V1, V2 + S I, aVL - S V1".心电图对肺动脉高压的诊断准确性及“RV1、V2 + SI、aVL - SV1”的作用
J Clin Med. 2024 Dec 13;13(24):7613. doi: 10.3390/jcm13247613.
9
Novel Reference Equations for Pulmonary Artery Size and Pulsatility Using Echocardiography and Their Diagnostic Value in Pulmonary Hypertension.应用超声心动图建立肺动脉大小和搏动指数的新参考方程及其在肺动脉高压中的诊断价值。
Chest. 2024 Nov;166(5):1184-1196. doi: 10.1016/j.chest.2024.06.3805. Epub 2024 Jul 25.
10
An electrocardiogram-based AI algorithm for early detection of pulmonary hypertension.基于心电图的人工智能算法用于早期检测肺动脉高压。
Eur Respir J. 2024 Jul 25;64(1). doi: 10.1183/13993003.00192-2024. Print 2024 Jul.
急性肺栓塞后慢性血栓栓塞性肺动脉高压的非侵入性早期排除:InShape II研究
Thorax. 2021 Oct;76(10):1002-1009. doi: 10.1136/thoraxjnl-2020-216324. Epub 2021 Mar 23.
4
Evaluation of code-based algorithms to identify pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension patients in large administrative databases.在大型管理数据库中评估基于编码的算法以识别肺动脉高压和慢性血栓栓塞性肺动脉高压患者。
Pulm Circ. 2020 Nov 10;10(4):2045894020961713. doi: 10.1177/2045894020961713. eCollection 2020 Oct-Dec.
5
Deep learning to predict elevated pulmonary artery pressure in patients with suspected pulmonary hypertension using standard chest X ray.深度学习利用标准胸部 X 光片预测疑似肺动脉高压患者的肺动脉高压。
Sci Rep. 2020 Nov 17;10(1):19311. doi: 10.1038/s41598-020-76359-w.
6
Pulmonary Arterial Hypertension and Specialty Care Centers: We Had a Feeling; Now We Have Data.肺动脉高压与专科护理中心:我们曾有预感;如今我们有了数据。
Chest. 2020 Jul;158(1):28-30. doi: 10.1016/j.chest.2020.03.079. Epub 2020 Jul 2.
7
Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry.根据俄罗斯国家登记处,不同形式肺动脉高压初诊患者的临床和仪器特征。
Biomed Res Int. 2020 Jun 14;2020:6836973. doi: 10.1155/2020/6836973. eCollection 2020.
8
Time from symptom onset to final diagnosis of pulmonary arterial hypertension in Polish patients.波兰患者从症状出现到最终诊断为肺动脉高压的时间。
Kardiol Pol. 2020 Aug 25;78(7-8):750-752. doi: 10.33963/KP.15344. Epub 2020 May 7.
9
Artificial intelligence for early prediction of pulmonary hypertension using electrocardiography.利用心电图进行肺动脉高压的早期预测的人工智能。
J Heart Lung Transplant. 2020 Aug;39(8):805-814. doi: 10.1016/j.healun.2020.04.009. Epub 2020 Apr 23.
10
The 'great wait' for diagnosis in pulmonary arterial hypertension.肺动脉高压诊断中的“漫长等待”。
Respirology. 2020 Aug;25(8):790-792. doi: 10.1111/resp.13814. Epub 2020 Apr 1.